What dangers lurk ahead for new “blood thinner” medications?
Could we unwittingly be participating in our own destruction?
Not only that, but these new medications are exorbitantly expensive, as well.
Are they worth it in the long run?
Should we continue to use the ready stand-by?
The new meds have no antidote. The old one does.
Too little too late, or too much too soon?
Are we playing with fire?
Only time will tell.
—
Insight: Top heart doctors fret over new blood thinners
By Ransdell Pierson
NEW YORK (Reuters) – For millions of heart patients, a pair of new blood thinners have been heralded as the first replacements in 60 years for warfarin, a pill whose hardships and risks have deterred many from using the stroke-prevention medicine.
But growing complaints of risks and deaths tied to the new crop of drugs have made some top U.S. cardiologists hesitant to prescribe them. Some are proposing a more rigorous monitoring regimen for when they are used.
Most concerns revolve around Pradaxa, a twice daily pill from Boehringer Ingelheim that was approved by the U.S. Food and Drug Administration in October 2010 to prevent strokes in patients with an irregular heartbeat called atrial fibrillation. It was the first new oral treatment for that use since warfarin was introduced in the 1950s.
“The good news is Read the rest of this entry »